Pharmacy |
| ||
|
OTRIVIN Natru Vent |
|
| ||
Home » Prescription Drugs 12 » OTRIVIN Natru Vent Otrivine nasal spray contains the active ingredient xylometazoline which is a type of medicine called a decongestant. When this medicine is administered into the nose the xylometazoline works by acting on alpha receptors that are found in the walls of blood vessels in the linings of the nasal passages and sinuses. It causes these blood vessels to contract and narrow thereby decreasing blood flow into the linings of the nose and sinuses. This reduces swelling and the feeling of congestion. It also reduces the production of mucus helping to relieve a blocked nose. The nasal spray helps relieve congestion in a few minutes and the effect of the medicine lasts for up to 10 hours. As the medicine causes the blood vessels in the nose to contract it minimises the amount of medicine that is absorbed into the bloodstream from the nose. This means that the nasal drops have a relatively local effect in the nose and are unlikely to have side effects on other parts of the body. What is it used for? Relieving a blocked nose (nasal congestion) associated with colds flu sinusitis and nasal allergies (allergic rhinitis) such as hayfever. Buy OTRIVIN Natru Vent and other Prescription Drugs 12 products online at Medstore. 875
About OTRIVIN Natru Vent: Product Type: Prescription Drugs 12 OTRIVIN ( Natru-Vent Generic Xylometazoline ) OTRIVIN (Natru-Vent Generic Xylometazoline) Natru-Vent Generic Xylometazoline 0.1% w/v 10ml Spray Natru-Vent Generic Xylometazoline OTRIVIN
View more Prescription Drugs 12 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
